IL10 and colitis: AOS-M and AOS-H treatment could downregulate the IFN-γ level and upregulate the anti-inflammatory cytokine IL-10 level in the serum of DSS-induced colitis mice (p < 0.05), suggesting that AOS also have anti-inflammation ability in vivo.